CARLSBAD, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the third quarter of 2020 after market close on Thursday, November 12, 2020. In conjunction with the release, Acutus will host a conference

CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today reported financial results for its second quarter ended June 30, 2020. Recent Highlights: Reported revenue of $1.1 million in the second quarter of 2020, a 54% increase over the same quarter

Design Features Improve Handling and Deliverability to Enhance Efficiency CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB) today announces FDA 510(k) clearance of the second-generation AcQMap® 3D imaging and mapping catheter which builds on its predecessor,

Breakthrough Technology, Combined with Acutus Non-Contact Mapping May Enable Rapid, Safe and Effective Arrhythmia Treatment CARLSBAD, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc.  (NASDAQ:AFIB) today announced pre-clinical experimental results of a novel diagnostic and

CARLSBAD, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the second quarter of 2020 after market close on Thursday, September 17, 2020. In conjunction with the release, Acutus will host a

CARLSBAD, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB),  today announced the closing of its initial public offering of 10,147,058 shares of common stock, which includes the exercise in full of the underwriters’ option to purchase 1,323,529 additional

CARLSBAD, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (NASDAQ: AFIB) today announced the pricing of its initial public offering of 8,823,529 shares of its common stock at a price to the public of $18.00 per share. All of the shares are being offered by Acutus.

ST. LOUIS and CARLSBAD, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Acutus Medical today announced the first integrated cardiac ablation procedure benefiting from remote TeleRobotic Support. Dr. Gery Tomassoni of Baptist Health in Lexington, KY treated the patient

A New Strategic Alliance Between BIOTRONIK, A Leader In Cardiac Rhythm Management, and Acutus Medical, Electrophysiology Innovator, Expected to Offer More Efficient and Effective Diagnosis and Treatment for Arrhythmia Patients CARLSBAD, California, and BERLIN, Germany, May 20, 2020 – Acutus Medical

Breakthrough Technology Enables Super-Fast Electrical Mapping and Re-Mapping of the Entire Heart Chamber – Leading to Rapid, Efficient and Individualized Ablation Strategies Carlsbad, Calif., February 18, 2020 – Acutus Medical today announced FDA clearance and CE Mark of SuperMap – a revolutionary